Investing

EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 87 th Emerging Growth Conference on October 22 & 23, 2025. The Emerging Growth Conference identifies companies…

(TheNewswire) Brossard, Quebec TheNewswire – October 22, 2025 CHARBONE CORPORATION (TSXV: CH,OTC:CHHYF; OTCQB: CHHYF; FSE: K47) (‘ CHARBONE ‘ or the ‘ Company ‘), a North American producer and distributor…

Substantial Assays Strengthen Shallow Central-South Mineralization and Support Robust Outlook for Upcoming Preliminary Economic Assessment Allied Critical Metals Inc. (CSE: ACM,OTC:ACMIF) (OTCQB: ACMIF) (FSE: 0VJ0) (‘Allied’ or the ‘Company’), which…

Trading resumes in: Company: West High Yield (W.H.Y.) Resources Ltd. TSX-Venture Symbol: WHY All Issues: Yes Resumption (ET): 8:00 AM CIRO can make a decision to impose a temporary suspension…

Here’s a quick recap of the crypto landscape for Wednesday (October 22) as of 9:00 a.m. UTC. Get the latest insights on Bitcoin, Ether and altcoins, along with a round-up…

Regeneration, a Washington-based public benefit company, is turning abandoned mine waste in the river valleys of Yukon and British Columbia into responsibly sourced gold. Founded out of the nonprofit Resolve,…

Australian Prime Minister Anthony Albanese and US President Donald Trump signed a rare earths deal during their meeting at the White House on Monday (October 20). The meeting was set…

Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for traders, including mining and defense stocks, reports on how critical mineral antimony is gaining government and investor attention as its…

The cleantech sector experienced a dynamic third quarter, with predictions of volatility coming to fruition. While global investment in renewable energy is strong, notable pullbacks in US spending and regulatory…

MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA. New data from…